Cargando…

P300 Interacted With N-Myc and Regulated Its Protein Stability via Altering Its Post-Translational Modifications in Neuroblastoma

MYCN amplification is an independent risk factor for poor prognosis in neuroblastoma (NB), but its protein product cannot be directly targeted because of protein structure. Thus, this study aimed to explore novel ways to indirectly target N-Myc by regulating its post-translational modifications (PTM...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cheng, Cheng, He, Tian, Chen, Kai, Cai, Yuanxia, Gu, Yaoyao, Pan, Lijia, Duan, Peiwen, Wu, Yeming, Wu, Zhixiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Biochemistry and Molecular Biology 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9984901/ https://www.ncbi.nlm.nih.gov/pubmed/36708875 http://dx.doi.org/10.1016/j.mcpro.2023.100504

Ejemplares similares

XPO1/CRM1 is a promising prognostic indicator for neuroblastoma and represented a therapeutic target by selective inhibitor verdinexor
por: Pan, Lijia, et al.
Publicado: (2021)

PCLAF promotes neuroblastoma G1/S cell cycle progression via the E2F1/PTTG1 axis
por: Liu, Xiaowei, et al.
Publicado: (2022)

Prp19 Is an Independent Prognostic Marker and Promotes Neuroblastoma Metastasis by Regulating the Hippo-YAP Signaling Pathway
por: Cai, Yuanxia, et al.
Publicado: (2020)

MCM6 indicates adverse tumor features and poor outcomes and promotes G1/S cell cycle progression in neuroblastoma
por: Gu, Yaoyao, et al.
Publicado: (2021)

Annexin A2 could enhance multidrug resistance by regulating NF-κB signaling pathway in pediatric neuroblastoma
por: Wang, Yi, et al.
Publicado: (2017)

15,16-dihydrotanshinone I inhibits EOMA cells proliferation by interfering in posttranscriptional processing of hypoxia-inducible factor 1
por: Duan, Peiwen, et al.
Publicado: (2021)

HAUSP deubiquitinated and stabilizes N-Myc in neuroblastoma
por: Tavana, Omid, et al.
Publicado: (2016)

Bufalin exerts antitumor effects in neuroblastoma via the induction of reactive oxygen species-mediated apoptosis by targeting the electron transport chain
por: Pan, Lijia, et al.
Publicado: (2020)

Pan-cancer analyses reveal the regulation and clinical outcome association of PCLAF in human tumors
por: Liu, Xiaowei, et al.
Publicado: (2022)

The deubiquitinating enzyme UCHL1 is a favorable prognostic marker in neuroblastoma as it promotes neuronal differentiation
por: Gu, Yuting, et al.
Publicado: (2018)

Phosphoproteomics reveals ALK promote cell progress via RAS/JNK pathway in neuroblastoma
por: Chen, Kai, et al.
Publicado: (2016)

Successful thoracoscopic repair of traumatic diaphragmatic hernia in a child
por: Wang, Yi, et al.
Publicado: (2021)

Editorial: Exploring the subcellular proteome and its post-translational modifications
por: Zhang, Shen, et al.
Publicado: (2022)

The Role of Hypoxia-Inducible Factor Post-Translational Modifications in Regulating Its Localisation, Stability, and Activity
por: Albanese, Adam, et al.
Publicado: (2020)

Coamplification of the L‐myc and N‐myc Oncogenes in a Neuroblastoma Cell Line
por: Jinbo, Takeshi, et al.
Publicado: (1989)

MDM2 regulates MYCN mRNA stabilization and translation in human neuroblastoma cells
por: Gu, Lubing, et al.
Publicado: (2011)

Recent Progress in Lymphangioma
por: Liu, Xiaowei, et al.
Publicado: (2021)

INSM1 increases N-myc stability and oncogenesis via a positive-feedback loop in neuroblastoma
por: Chen, Chiachen, et al.
Publicado: (2015)

AMPLIFIED ALLELE OF THE HUMAN N‐myc ONCOGENE IN NEUROBLASTOMAS
por: Yamada, Masao, et al.
Publicado: (1988)

Target RNA modification for epigenetic drug repositioning in neuroblastoma: computational omics proximity between repurposing drug and disease
por: Ma, Pei, et al.
Publicado: (2020)

NSD3S stabilizes MYC through hindering its interaction with FBXW7
por: Gonzalez-Pecchi, Valentina, et al.
Publicado: (2019)

Stopping MYC in its tracks
por: Stefan, Eduard, et al.
Publicado: (2015)

Post-Translational Modification and Subcellular Distribution of Rac1: An Update
por: Abdrabou, Abdalla, et al.
Publicado: (2018)

Control of protein stability by post-translational modifications
por: Lee, Ji Min, et al.
Publicado: (2023)

CIP2A regulates MYC translation (via its 5′UTR) in colorectal cancer
por: Denk, S., et al.
Publicado: (2020)

The inflammatory kinase IKKα phosphorylates and stabilizes c-Myc and enhances its activity
por: Moser, Bernhard, et al.
Publicado: (2021)

Methyl-Coenzyme M Reductase and Its Post-translational Modifications
por: Chen, Hao, et al.
Publicado: (2020)

Post-translational modification of Parkin and its research progress in cancer
por: Ding, Dan, et al.
Publicado: (2019)

p300- and Myc-mediated regulation of glioblastoma multiforme cell differentiation
por: Panicker, Sreejith P., et al.
Publicado: (2010)

EP300 Selectively Controls the Enhancer Landscape of MYCN-Amplified Neuroblastoma
por: Durbin, Adam D., et al.
Publicado: (2022)

Effects of Nonstarch Genetic Modifications on Starch Structure and Properties
por: Yu, Shiyao, et al.
Publicado: (2020)

“Myc’ed Messages”: Myc Induces Transcription of E2F1 while Inhibiting Its Translation via a microRNA Polycistron
por: Coller, Hilary A, et al.
Publicado: (2007)

A New Player in Neuroblastoma: YAP and Its Role in the Neuroblastoma Microenvironment
por: Shim, Jenny, et al.
Publicado: (2021)

Metastasis in Neuroblastoma and Its Link to Autophagy
por: Jahangiri, Leila
Publicado: (2023)

Post-translational modifications of PRC2: signals directing its activity
por: Yang, Yiqi, et al.
Publicado: (2020)

Post-Translational Modification of MRE11: Its Implication in DDR and Diseases
por: Lu, Ruiqing, et al.
Publicado: (2021)

Urinary 3-Methoxytyramine Is a Biomarker for MYC Activity in Patients With Neuroblastoma
por: Verly, Iedan R. N., et al.
Publicado: (2022)

Mitoribosomal synthetic lethality overcomes multidrug resistance in MYC-driven neuroblastoma
por: Borankova, Karolina, et al.
Publicado: (2023)

HSPC300 and its role in neuronal connectivity
por: Qurashi, Abrar, et al.
Publicado: (2007)

HIF-1α Contributes to Proliferation and Invasiveness of Neuroblastoma Cells via SHH Signaling
por: Chen, Sheng, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_9tqi9u2hi7vdtdd0r4c6c2ltln